| scholarly article | Q13442814 |
| P2093 | author name string | Ping Liang | |
| Jun Cui | |||
| Xiao-Ling Yu | |||
| Bao-Wei Dong | |||
| De-Jiang Yu | |||
| P2860 | cites work | Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival | Q28189986 |
| Correlation of c-myc gene amplification, MTS1/p16 gene alternation, and HBV infection in human hepatocellular carcinoma | Q30755157 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues | Q36308973 | ||
| Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? | Q38520141 | ||
| Distinctive gene expression profiles associated with Hepatitis B virus x protein | Q40794517 | ||
| Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells | Q43580222 | ||
| Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung. | Q43642266 | ||
| Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery | Q44926653 | ||
| Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme. | Q52831092 | ||
| The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways. | Q54742147 | ||
| Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma | Q58033435 | ||
| Prognostic significance ofc-myc andAIB1 amplification in hepatocellular carcinoma | Q58321632 | ||
| [Experimental therapy of adenovirus-transferred antisense c-myc on hepatocellular cancer cell] | Q64379263 | ||
| Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma | Q73083466 | ||
| EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation | Q73651365 | ||
| Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma | Q73657791 | ||
| Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma | Q73698911 | ||
| Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma | Q74001305 | ||
| Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis | Q74067195 | ||
| A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas | Q74189308 | ||
| [Relationship between serum matrix metalloproteinase-2 and metastasis and recurrence following radical hepatic resection in hepatocellular carcinoma] | Q74386721 | ||
| [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma] | Q75200972 | ||
| Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival | Q77626767 | ||
| [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization] | Q77696531 | ||
| Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma | Q77869615 | ||
| Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma | Q78592178 | ||
| A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma | Q79217658 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1533-1536 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection | |
| P478 | volume | 10 |
| Q45415153 | A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. |
| Q47285445 | Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice |
| Q37809119 | Angiogenesis in chronic liver disease and its complications |
| Q36233584 | Anti-angiogenic strategies in gastrointestinal malignancies |
| Q51815043 | Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? |
| Q33837248 | Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma |
| Q35698574 | HCC and angiogenesis: possible targets and future directions |
| Q33695543 | Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma |
| Q28483727 | Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA |
| Q47325009 | Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma |
| Q52565829 | Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection. |
| Q53283424 | Post-TACE combination therapy of heparin and octreotide results in decreased tumor metastasis in extrahepatic tumorigenesis. |
| Q38188582 | Review of angiogenesis in hepatocellular carcinoma |
| Q27486114 | The FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C Virus |
| Q43828352 | The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus-related hepatocellular carcinoma |
| Q37564297 | Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature |
| Q64964297 | c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients. |
| Q38908811 | mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma |
Search more.